College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.
Advanced Innovation Center for Human Brain Protection, and National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital Capital Medical University, Beijing 100053, People's Republic of China.
Stem Cells. 2023 Mar 2;41(2):111-125. doi: 10.1093/stmcls/sxac088.
Glioblastoma stem cells (GSCs) contributed to the progression, treatment resistance, and relapse of glioblastoma (GBM). However, current researches on GSCs were performed usually outside the human tumor microenvironment, ignoring the importance of the cellular states of primary GSCs. In this study, we leveraged single-cell transcriptome sequencing data of 6 independent GBM cohorts from public databases, and combined lineage and stemness features to identify primary GSCs. We dissected the cell states of GSCs and correlated them with the clinical outcomes of patients. As a result, we constructed a cellular hierarchy where GSCs resided at the center. In addition, we identified and characterized 2 different and recurrent GSCs subpopulations: proliferative GSCs (pGSCs) and quiescent GSCs (qGSCs). The pGSCs showed high cell cycle activity, indicating rapid cell division, while qGSCs showed a quiescent state. Then we traced the processes of tumor development by pseudo-time analysis and tumor phylogeny, and found that GSCs accumulated throughout the whole tumor development period. During the process, pGSCs mainly contributed to the early stage and qGSCs were enriched in the later stage. Finally, we constructed an 8-gene prognostic signature reflecting pGSCs activity and found that patients whose tumors were enriched for the pGSC signature had poor clinical outcomes. Our study highlights the primary GSCs heterogeneity and its correlation to tumor development and clinical outcomes, providing the potential targets for GBM treatment.
胶质母细胞瘤干细胞(GSCs)是导致胶质母细胞瘤(GBM)进展、治疗耐药和复发的原因之一。然而,目前针对 GSCs 的研究通常是在体外进行的,忽略了原发性 GSCs 细胞状态的重要性。在这项研究中,我们利用来自公共数据库的 6 个独立 GBM 队列的单细胞转录组测序数据,并结合谱系和干性特征来识别原发性 GSCs。我们剖析了 GSCs 的细胞状态,并将其与患者的临床结果相关联。结果,我们构建了一个以 GSCs 为中心的细胞层次结构。此外,我们还鉴定并描述了两种不同且反复出现的 GSCs 亚群:增殖性 GSCs(pGSCs)和静止性 GSCs(qGSCs)。pGSCs 表现出高细胞周期活性,表明快速细胞分裂,而 qGSCs 则处于静止状态。然后,我们通过伪时间分析和肿瘤系统发生追踪肿瘤的发展过程,发现 GSCs 在整个肿瘤发展期间都在积累。在这个过程中,pGSCs 主要在早期阶段发挥作用,而 qGSCs 在晚期阶段富集。最后,我们构建了一个反映 pGSCs 活性的 8 基因预后标志物,并发现肿瘤中富含 pGSC 标志物的患者临床结局较差。我们的研究强调了原发性 GSCs 的异质性及其与肿瘤发展和临床结果的相关性,为 GBM 的治疗提供了潜在的靶点。